|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb » |
Fluorine in PDB 4ccb: Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-AmineEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb
was solved by
M.Mctigue,
Y.Deng,
W.Liu,
A.Brooun,
A.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
(pdb code 4ccb). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb: Fluorine binding site 1 out of 1 in 4ccbGo back to Fluorine Binding Sites List in 4ccb
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
Mono view Stereo pair view
Reference:
Q.Huang,
T.W.Johnson,
S.Bailey,
A.Brooun,
K.D.Bunker,
B.J.Burke,
M.R.Collins,
A.Cook,
J.J.Cui,
K.N.Dack,
J.G.Deal,
Y.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.Hoffman,
R.L.Hoffman,
H.Shen,
P.Johnson,
R.S.Kania,
H.Lam,
J.L.Lam,
P.Le,
Q.Li,
L.Lingardo,
W.Liu,
M.West Lu,
M.A.Mctigue,
C.L.Palmer,
P.F.Richardson,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
K.Tsaparikos,
H.Wang,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.Edwards.
The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. V. 57 1170 2014.
Page generated: Thu Aug 1 00:42:00 2024
ISSN: ISSN 0022-2623 PubMed: 24432909 DOI: 10.1021/JM401805H |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |